Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Kidron Miriam received 417,416 Oramed Pharmaceuticals Inc. shares as an award (Form 4)
Traded Sep 24, 2026 · Filed Sep 25, 2026
On Sep 24, 2026, Kidron Miriam (Director, Chief Scientific Officer) received 417,416 Oramed Pharmaceuticals Inc. shares as an award, leaving 1,550,554 shares. Filed Sep 25, 2026 (Form 4).
- Awarded
- 417,416 shares
- Holding after
- 1,550,554 shares
- Trading plan
- No
- Role
- Director, Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Common Stock | Award | 208,125 | 1,341,263 | Direct | |
| Sep 24, 2026 | Common Stock | Award | 209,291 | 1,550,554 | Direct |